# Eye screening that reached a million people.

Agent contract: 1.2.0

Doctors in India, Thailand and Australia describe what it actually took to run the same diabetic-eye-screening AI across more than a million patients — the practical lessons, not just the accuracy.

Canonical: https://brightaifuture.com/discoveries/retinopathy-scaling
Format: discovery
Source publication: 2026-09-23
Bright publication: 2026-09-27
Substantive update: None recorded
Evidence and review: Deployed; confidence: medium; source-checked; ai-assisted. AI-assisted source check against the Nature Medicine Comment. Alphabet-funded and authored in part by Alphabet employees; this is the authors’ deployment account, not independent verification.

## The human problem

Diabetic retinopathy can be caught early with screening, but many people never get a timely eye exam.

## The prior constraint

A screening tool that works in one hospital does not automatically work across different health systems and countries.

## AI’s actual role

A deep-learning tool read retinal images to flag people who needed a specialist referral, deployed across three health systems.

## The documented result

A Nature Medicine Comment reports the tool was deployed across Aravind Eye Care System (India), Rajavithi Hospital (Thailand) and Lions Outback Vision (Australia), screening over one million patients, and draws cross-cutting lessons for scaling healthcare AI.

## Why it may matter

It shows the human work behind scaling a medical AI — across clinics, countries and workflows — rather than a single accuracy figure.

## Limitations

This is a Comment reflecting on deployment, not a new controlled trial, and the work was funded by Alphabet Inc. with several authors employed by Alphabet; the lessons are the authors’ own account, not independent evaluation.

## Unresolved questions

How do screening yield and downstream treatment differ across these very different health systems?

## Provenance and history

{
  "dates": {
    "eventDate": null,
    "publicationDate": "2026-09-23",
    "captureDate": "2026-09-27",
    "lastReviewedDate": "2026-09-27"
  },
  "provenance": {
    "origin": "editorial",
    "externalId": "retinopathy-scaling"
  },
  "revisions": [
    {
      "id": "revision:intake-20260927-retinopathy-scaling",
      "recordedAt": "2026-09-27",
      "summary": "Added to Bright from the 27 Sep 2026 intake as a bounded, source-checked record; company funding disclosed.",
      "sourceIds": [
        "source:retinopathy-scaling"
      ]
    }
  ],
  "corrections": []
}

## Original sources

- [Practical lessons in the global scaling of clinical AI: from one hospital to over a million patients screened · Nature Medicine](https://www.nature.com/articles/s41591-026-04643-9)

## Continue exploring

- [Work & learning](https://brightaifuture.com/worlds/work)
- [When does a technical result become a public capability?](https://brightaifuture.com/threads/community)
